1. 2904 Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Independent review of a prospective ANOCEF randomized phase II trial. (September 2015) Authors: Tabouret, E.; Houillier, C.; Martin-Duverneuil, N.; Blonski, M.; Soussain, C.; Ghesquieres, H.; Houot, R.; Delwail, V.; Soubeyran, P.; Gressin, R.; Gyan, E.; Lemercier, S.; Chinot, O.; Taillandier, L.; Tanguy, M.L.; Antonio, O.; Hoang-Xuan, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study. Issue 5 (September 2015) Authors: Hermet, E.; Cabrespine, A.; Guièze, R.; Garnier, A.; Tempescul, A.; Lenain, P.; Bouabdallah, R.; Vilque, J.P.; Frayfer, J.; Bordessoule, D.; Sibon, D.; Janvier, M.; Caillot, D.; Biron, P.; Legros, L.; Choufi, B.; Drenou, B.; Gorin, N.C.; Bilger, K.; Tamburini, J. Journal: Journal of geriatric oncology Issue: Volume 6:Issue 5(2015) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CHECKMATE 647: A PHASE 2, OPEN‐LABEL STUDY OF NIVOLUMAB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OR RELAPSED/REFRACTORY PRIMARY TESTICULAR LYMPHOMA. (June 2017) Authors: Nayak, L.; Iwamoto, F.M.; Ferreri, A.J.; Santoro, A.; Singer, S.; Batlevi, C.; Batchelor, T.; Rubenstein, J.; Johnston, P.; Ramchandren, R.; Soussain, C.; Drappatz, J.; Becker, K.; Witzens‐Harig, M.; Illerhaus, G.; Herrera, A.; Masood, A.; Shipp, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO‐RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END‐POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK. (June 2017) Authors: Soussain, C.; Choquet, S.; Houillier, C.; Bijou, F.; Houot, R.; Boyle, E.; Gressin, R.; Nicolas‐Virelizier, E.; Barrie, M.; Moluçon‐Chabrot, C.; Lelez, M.; Clavert, A.; Coisy, S.; de la Bretonnière, M. Ertault; El Yamani, A.; Touitou, V.; Cassoux, N.; Boussetta, S.; Broussais, F.; Gelas‐Dore, B. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. (August 2019) Authors: Soussain, C.; Choquet, S.; Blonski, M.; Leclercq, D.; Houillier, C.; Rezai, K.; Bijou, F.; Houot, R.; Boyle, E.; Gressin, R.; Nicolas-Virelizier, E.; Barrie, M.; Moluçon-Chabrot, C.; Lelez, M.L.; Clavert, A.; Coisy, S.; Leruez, S.; Touitou, V.; Cassoux, N.; Daniau, M. Journal: European journal of cancer Issue: Volume 117(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL WORLD IN FRANCE. (23rd June 2022) Authors: Ghesquieres, H.; Cherblanc, F.; Belot, A.; Camus, V.; Thokagevistk, K.; Bouabdallah, K.-K.; Esnault, C.; Fornecker, L.-M.; Micon, S.; Bijou, F.; Haioun, C.; Morineau, N.; Ysebaert, L.; Damaj, G.; Le Gouill, S.; Guidez, S.; Morschhauser, F.; Thiéblemont, C.; Chauchet, A.; Gressin, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY. (23rd June 2022) Authors: Mohty, M.; Yakoub-Agha, I.; Dalle, J.-H.; Labopin, M.; Cornillon, J.; Huynh, A.; Lamy, T.; Soussain, C.; Asubonteng, K.; Gutierrez, D.; Peffault de Latour, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA. (23rd June 2022) Authors: Soussain, C.; Grommes, C.; Ward, R.; Peterson, C.; Cravets, M.; Mathias, A.; Sosa, J.; Kirby, B.; Ding, Z.; Yusuf, I.; Rose, M.; Steinberg, M.; Tun, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHOMA: PRESENTATION, EFFECTS ON TUMOR TREATMENT AND OUTCOME IN A SERIES OF THE INTERNATIONAL PCNSL COLLABORATIVE GROUP. (17th June 2021) Authors: Ferreri, A. J. M.; Steffanoni, S.; Calimeri, T.; Laurenge, A.; Fox, C. P.; Soussain, C.; Grommes, C.; Sassone, M. C.; Touat, M.; Boot, J.; Crosbie, N.; Chaganti, S.; Dietrich, J.; Alencar, A.; Itchaki, G.; Hoang Xuan, K.; Batchelor, T.; Cwynarski, K. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TEMOZOLOMIDE IN RELAPSE/REFRACTORY PRIMARY VITREO‐RETINAL LYMPHOMA (R/R PVRL): A SIMPLE, CHEAP, EFFECTIVE AND WELL TOLERATED TREATMENT. RESULT OF THE LARGEST STUDY ON R/R PVRL, FROM THE LOC NETWORK. (12th June 2019) Authors: Choquet, S.; Baron, M.; Soussain, C.; Houillier, C.; Gyan, E.; Soubeyran, P.; Cassoux, N.; Touitou, V.; Bodaghi, B.; Hoang‐Xuan, K.; Leblond, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗